NuroMENA

NuroMENA is a specialty pharmaceutical company headquartered in Dubai, UAE, dedicated to the Central Nervous System (CNS) therapeutic area within the Middle East and North Africa (MENA) region. The company focuses on providing innovative healthcare solutions for neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and epilepsy. NuroMENA operates through a hybrid model of internal portfolio management and strategic partnerships with global biotech and pharmaceutical firms to commercialize advanced therapies in regional markets. Their expertise encompasses regulatory affairs, market access, and specialized medical marketing tailored to the unique healthcare landscape of the MENA region. By bridging the gap between global innovation and regional patient needs, NuroMENA aims to improve the quality of life for patients suffering from debilitating brain disorders.